Agent for decreasing the adhesion of monocytes to endothelial cells

Translated title of the contribution: Līdzeklis monocītu adhēzijas pie endotēlija šūnām pazemināšanai

Jeļena Krasiļņikova (Inventor), Gaļina Teliševa (Inventor), Liga Lauberte (Inventor), Elena Kistanova (Inventor), Desislava Abadjieva (Inventor), Elena Stoyanova (Inventor), Laurent-Emmanuel, Jean-Baptiste, Alexandre MONFOULET (Inventor)

Research output: Intellectual propertyPatent

Abstract

The invention relates to medicinal substances for decreasing the adhesion of monocytes to endothelial cells. The substance is oregonin.
Translated title of the contributionLīdzeklis monocītu adhēzijas pie endotēlija šūnām pazemināšanai
Original languageLatvian
Patent number15531
IPCA61K31/7034,A61P9/00
Priority date8/05/19
Filing date8/05/19
Publication statusPublished - 20 Jun 2021

Keywords*

  • substances for decreasing the adhesion of monocytes to endothelial cells
  • oregonin

Field of Science*

  • 3.2 Clinical medicine

Patent expiration date

  • 30.11.2022

Fingerprint

Dive into the research topics of 'Līdzeklis monocītu adhēzijas pie endotēlija šūnām pazemināšanai'. Together they form a unique fingerprint.

Cite this